17 AprilAnalyst Stuart RobertsAssociate Analyst Tanushree Jain

First Page		Document Content
Date: 2014-02-16 20:47:19 Protease inhibitors Health HIV/AIDS Virology Hepatitis Peginterferon alfa-2a MiR-122 Hepatitis C virus Telaprevir Biology Medicine Antivirals		17 AprilAnalyst Stuart RobertsAssociate Analyst Tanushree Jain Add to Reading List Source URL: www.biotron.com.au Download Document from Source Website File Size: 1,02 MB Share Document on Facebook

	Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis DocID: 19W6r - View Document
	Article in press - uncorrected proof Clin Chem Lab Med 2011;49(10):xxx-xxx 2011 by Walter de Gruyter • Berlin • Boston. DOICCLMReview Prognostic, therapeutic and diagnostic potential of microRNA DocID: 19zws - View Document
	Downloaded from rnajournal.cshlp.org on July 28, Published by Cold Spring Harbor Laboratory Press Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell Georgia Sotiropoulo DocID: 199TC - View Document
	miRNAs in macrophages and adipocytes - Supplemental Tables Table S1 Most significant differences regarding miRNAs availability in macrophages (M1) and adipocytes (MAs) and into supernatants (SN) at the basal level and u DocID: 175SZ - View Document
	A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients DocID: 160Pd - View Document